BRIL imaging technologies encompass current major in vivo imaging modalities such as high frequency ultrasound, positron emission tomography (PET), micro computed tomography (microCT), and optical imaging (bioluminescence and fluorescence). The data from imaging platforms such as microPET-CT and ultrasound can have maximal clinical relevance, allowing quick bench-to-bedside technology transfer.
The 9.4 Tesla pre-clinical magnetic resonance imaging (MRI) system provides access to high resolution imaging and spectroscopy for small animals, clinical tissues and materials. With the recent addition of a cryocoil platform for increased sensitivity, the facility is the best equipped of its kind in Australia and is competitive with any in the world, placing UNSW at the forefront of biomedical imaging.
BRIL is part of the Australian National Imaging Facility (NIF) funded under the National Collaborative Research Infrastructure Strategy (NCRIS). The NIF network covers a wide spectrum of imaging to cater to national and international research needs.